InMed Pharmaceuticals Inc. - 8-K Filing
Mentari Therapeutics, Inc. (formerly InMed Pharmaceuticals Inc.) completed a business combination with Mentari on November 6, 2026. (Items: 3.03 of this Current Report on Form 8-K, InMed redomesticated from the Province of British Columbia, Canada to the State of Nevada by way of a con, 1.01 Entry into a Material Definitive Agreement, 2.01 Completion of Acquisition or Disposition of Assets, 5.02 of this Current Report on Form 8-K under the heading “Appointment of Directors and Certain Officers” is incorporated herein by reference)
Tickers: $INM
Read the full article at SEC EDGAR
Part of the story InMed Pharmaceuticals Inc. - 8-K Filing (3 articles)